3M Completes Divestment of Drug Delivery DivisionMay 5, 2020
The US$650 million divestment was announced late last year. Per the terms of the sale, more than 900 employees of the division, which produces inhalers, micro-needles, and other technologies, will transfer to Altaris, which will operate the segment as a new company known as Kindeva Drug Delivery.
With global sales of US$33 billion, 3M is a leading producer of thousands of products ranging from chemicals, filtration systems, and safety and protection equipment to office, graphics, and health care equipment. For more information, visit www.3m.com.